Serotonin syndrome.

By Š. Alušík, D. Kalátová, Z. Paluch. Neuro - endocrinology letters, 2014

971 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Treatment-resistant depression: therapeutic trends, challenges, and future directions (2012, neutral): “Serotonin syndrome, 70 reflecting toxic serotonin levels in the central nervous system and characterized by hyperalertness, agitation, confusion, restlessness, myoclonus, hyperreflexia, diaphoresis, shivering, tremor, and, possibly, death, may occasionally develop if the washout period was…”
Major depression. (2014, background): “A seminal New England Journal of Medicine review in 2005 describes a clinical triad of mental status changes, autonomic hyperactivity, and neuromuscular abnormalities that characterize the syndrome.(120) The review describes neuromuscular changes that start with symptoms of akathisia then progress t”